TradingAgents AISign inGet started
All stock profiles
AKANNASDAQHealthcare

AKANDA CORP

Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.

Latest price

$1.04

-5.45%

Alpha Vantage · 10/30/2026

Industry: Drug Manufacturers - Specialty & GenericCategory: ADR Common StockCurrency: USDNews: 0 recent
Analyze AKAN free

One-year price history

Adjusted daily closes · 252 observations · as of Oct 30, 2026

Historical data, not a forecast

1 month

-52.9%

3 months

-80.7%

6 months

-98.2%

1 year

-97.1%

Year to date

-89.9%

52-week range

$1.01 – $57.09

Fundamental snapshot

Latest reported period: Jun 30, 2026

Sharadar reported data

Market cap

$800K

P/E

0

P/B

-0.1

P/S

1.2

Revenue

$662.47K

Net income

-$51.04M

Diluted EPS

-647.62

Gross margin

-12.00%

Net margin

-7703.80%

Return on equity

856.60%

Total debt

$18.57M

Cash

$755.24K

Free cash flow

-$12.05M

Latest eight reported quarters

Reported quarterly values, newest first

PeriodRevenueNet incomeGross marginNet marginFree cash flow
Jun 30, 2026—————
Dec 31, 2025—————
Jun 30, 2025—————
Jun 30, 2025—————
Dec 31, 2024—————
Dec 31, 2024—————
Jun 30, 2024—————
Dec 31, 2023—————

Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.

Recent AKAN news

All market news

No ticker-linked stories are in the current archive.